Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species

British Journal of Dermatology

Volumn 140, Issue 3, 1999, Pages 480-482

  Hamm, H ^a   Schwinn, A ^a   Brautigam M ^b   Weidinger, G ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Novartis Pharma GmbH   (Germany)

Author keywords

Microsporum canis; Terbinafine; Tinea capitis; Trichophyton species

Indexed keywords

TERBINAFINE;

ABDOMINAL PAIN; ADOLESCENT; ANTIFUNGAL ACTIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; EPISTAXIS; FACE EDEMA; FEMALE; FEVER; HUMAN; MALE; MICROSPORUM CANIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; MALE; MICROSPORUM; NAPHTHALENES; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

EID: 0032915514     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02713.x     Document Type: Article

References (8)

1. 1 Fieden IJ. Tinea capitis: epidemiology, diagnosis, treatment and control. J Am Acad Dermatol 1994; 31: S42-6.
2. 2 Jolly H. A comparison of the effects of ketoconazole and griscofulvin. In: Oral Therapy of Dermȧtomycoses: a Step Forward (Meinhof W, ed.). Oxford: Medicine Publication Fund, 1985: 79-83.
3. 3 Villars V. Jones TC. Present status of the efficacy and tolerability of terbinafine (Lamisil) used systematically in the treatment of dermatomycoses of skin and nail. J Dermatol Treat 1990: 1; (Suppl. 2) 33-8.
4. 4 Jones TC. Overview of the use of terbinafine (Lamisil) in children. Br J Dermatol 1995; 132: 683-9.
5. 5 Clayton YM. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol 1994; 130; (Suppl. 43): 7-8.
6. 6 Haroon TS, Hussain I, Mahmood A et al. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis. Br J Dermatol 1992; 126; (Suppl. 39); 47-50.
7. 7 Haroon TS, Hussain T. Aman S et al. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. Br J Dermatol 1996; 135: 86-8.
8. 8 Talarico Fo S, Arruda LHF, Cucé LC et al. Efficacy and tolerability of Lamisil® (terbinafine) tablets in the treatment of children with tinea capitis. J Eur Acad Dermatol Venereol 1995; 5; (Suppl. 1): S172.